X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Merck Ltd Fact Sheet, Merck Ltd Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Merck Ltd Fact Sheet   (EMER)

Here is the latest financial fact sheet of Merck Ltd. For more details, see the Merck Ltd quarterly results and Merck Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

MERCK LTD Price History

Price Rs 1,978.6
Mkt Cap Rs m 32,844
Vol '000 6.1
P/E X 38.7
P/CF X 31.8
EPS (TTM) Rs 51.1
% ch % 5.7
No. of shares m 16.60
% ch week % -1.0
% ch 1-mth % 5.5
% ch 12-mth % 95.5
52 week H/L Rs 2,272.0/977.0
(As on May 25, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

MERCK LTD Financials

No. of Mths
Year Ending
12
Dec-12
12
Dec-13
12
Dec-14
12
Dec-15
12
Dec-16
5-Yr Chart
Click to enlarge
MERCK LTD EQUITY SHARE DATA
High Rs7146899191,0041,060 
Low Rs555523536716623 
Sales per share (Unadj.) Rs414.0480.6522.6566.0632.4 
Earnings per share (Unadj.) Rs47.233.726.032.345.7 
Diluted earnings per shareRs47.233.726.032.345.7 
Cash flow per share (Unadj.) Rs52.639.733.746.462.3 
Dividends per share (Unadj.) Rs2.508.506.007.5011.00 
Adj. dividends per shareRs2.508.506.007.5011.00 
Dividend yield (eoy) %0.41.40.80.91.3 
Book value per share (Unadj.) Rs291.4315.1333.9356.4388.8 
Adj. book value per shareRs291.4315.1333.9356.4388.8 
Shares outstanding (eoy) m16.6016.6016.6016.6016.60 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.51.31.41.51.3 
Avg P/E ratio x13.418.027.926.718.4 
P/CF ratio (eoy) x12.115.221.618.513.5 
Price / Book Value ratio x2.21.92.22.42.2 
Dividend payout %5.325.323.023.224.1 
Avg Mkt Cap Rs m10,53310,05612,07514,27613,969 
No. of employees `0001.31.51.51.61.6 
Total wages/salary Rs m8531,0101,1361,2341,487 
Avg. sales/employee Rs Th5,382.05,332.85,726.06,045.76,631.9 
Avg. wages/employee Rs Th668.0674.9749.6794.0939.2 
Avg. net profit/employee Rs Th613.9373.5285.3344.7479.4 
MERCK LTD INCOME DATA
Net Sales Rs m6,8737,9788,6759,39510,498 
Other income Rs m202215203233242 
Total revenues Rs m7,0758,1928,8789,62810,741 
Gross profit Rs m1,0557695898341,135 
Depreciation Rs m89101127234276 
Interest Rs m00000 
Profit before tax Rs m1,1688836668331,102 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m384324233298343 
Profit after tax Rs m784559432536759 
Gross profit margin %15.39.66.88.910.8 
Effective tax rate %32.936.735.135.731.1 
Net profit margin %11.47.05.05.77.2 
MERCK LTD BALANCE SHEET DATA
Current assets Rs m4,5854,7774,9865,7246,410 
Current liabilities Rs m9711,1201,3521,6598,828 
Net working cap to sales %52.645.841.943.3-23.0 
Current ratio x4.74.33.73.50.7 
Inventory Days Days7069756558 
Debtors Days Days3438444938 
Net fixed assets Rs m7699411,3731,3871,406 
Share capital Rs m166166166166166 
"Free" reserves Rs m4,6685,0625,3745,7476,286 
Net worth Rs m4,8375,2305,5435,9166,455 
Long term debt Rs m00000 
Total assets Rs m5,9436,4837,0827,8408,828 
Interest coverage xNMNMNMNMNM 
Debt to equity ratio x00000 
Sales to assets ratio x1.21.21.21.21.2 
Return on assets %13.28.66.16.88.6 
Return on equity %16.210.77.89.111.8 
Return on capital %24.116.912.014.117.1 
Exports to sales %10.68.97.88.58.3 
Imports to sales %22.423.722.821.621.0 
Exports (fob) Rs m730708677802869 
Imports (cif) Rs m1,5401,8881,9812,0262,209 
Fx inflow Rs m802746824874959 
Fx outflow Rs m1,8962,2812,3112,3562,612 
Net fx Rs m-1,094-1,535-1,487-1,483-1,653 
MERCK LTD CASH FLOW
From Operations Rs m 543 5 50 835 1,070 
From Investments Rs m -818 70 106 -678 -750 
From Financial Activity Rs m 0 -48 -166 -119 -150 
Net Cashflow Rs m -276 27 -11 37 171 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 51.8%
Indian inst/Mut Fund 18.2%
FIIs 1.0%
ADR/GDR 0.0%
Free float 29.1%
Shareholders 28,591
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Shiv Sagar Estate 'A', Dr. Annie Besant Road, Worli, Mumbai - 400 018
E-MAIL vikas.r.gupta@merckgroup.com WEB www.merck.co.in
TELEPHONE (022) 6660 9111 FAX (022) 2495 0307
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
AUDITOR B. S. R & Co.
CHM: S. N. Talwar COMP SEC: Vikas R. Gupta YEAR OF INC: 1967 BSE CODE: 500126 FV (Rs): 10 DIV YIELD (%): 0.6

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA  ALEMBIC PHARMA  SUVEN LIFE  DIVIS LABORATORIES  ALKEM LABORATORIES  

Compare MERCK LTD With:   AUROBINDO PHARMA  ALEMBIC PHARMA  SUVEN LIFE  DIVIS LABORATORIES  ALKEM LABORATORIES  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MERCK LTD

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS